Development of Machine Learning Models for Accurately Predicting and Ranking the Activity of Lead Molecules to Inhibit PRC2 Dependent Cancer
Disruption of epigenetic processes to eradicate tumor cells is among the most promising interventions for cancer control. EZH2 (Enhancer of zeste homolog 2), a catalytic component of polycomb repressive complex 2 (PRC2), methylates lysine 27 of histone H3 to promote transcriptional silencing and is...
Päätekijät: | Danishuddin, Vikas Kumar, Shraddha Parate, Ashutosh Bahuguna, Gihwan Lee, Myeong Ok Kim, Keun Woo Lee |
---|---|
Aineistotyyppi: | Artikkeli |
Kieli: | English |
Julkaistu: |
MDPI AG
2021-07-01
|
Sarja: | Pharmaceuticals |
Aiheet: | |
Linkit: | https://www.mdpi.com/1424-8247/14/7/699 |
Samankaltaisia teoksia
-
CBF-1 Promotes the Establishment and Maintenance of HIV Latency by Recruiting Polycomb Repressive Complexes, PRC1 and PRC2, at HIV LTR
Tekijä: Adhikarimayum Lakhikumar Sharma, et al.
Julkaistu: (2020-09-01) -
Differentiating Drosophila female germ cells initiate Polycomb silencing by regulating PRC2-interacting proteins
Tekijä: Steven Z DeLuca, et al.
Julkaistu: (2020-08-01) -
The competence paradigm of the future teacher of choreography: the experience of the PRC
Tekijä: O. Bashkir, et al.
Julkaistu: (2022-10-01) -
Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function
Tekijä: Zhiwei Zhou, et al.
Julkaistu: (2017-11-01) -
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer
Tekijä: Wenqian Yu, et al.
Julkaistu: (2024-08-01)